Regulatory Beat

Feb 01, 2016
BioPharm International
FDA and industry see progress and challenges in bringing cutting-edge medicines to patients.
Dec 01, 2015
BioPharm International
FDA confirmed quality focus while Congress moved to bolster biomedical innovation.
Nov 01, 2015
BioPharm International
New program emphasizes quality, risk, and global collaboration.
Sep 15, 2015
BioPharm International
Manufacturers challenge details in new policies designed to promote access to important therapies.
Sep 01, 2015
BioPharm International
Legislation to streamline drug development may get tangled up in user fee negotiations and drug pricing battles.
Aug 01, 2015
BioPharm International
FDA and industry support global framework and collaborations to secure the supply chain.
Jul 01, 2015
BioPharm International
Manufacturers and FDA look for innovative strategies to meet accelerated timeframes.
Jul 01, 2015
BioPharm International
The European Union has a challenging task ahead as it strives to harmonize regulations on advanced therapy medicinal products.
Jun 01, 2015
BioPharm International
Regulators and industry seek to streamline and harmonize oversight of postapproval changes.
May 01, 2015
BioPharm International
Drug manufacturers face added pressure and incentives for meeting new FDA compliance policies and priorities.
native1_300x100
lorem ipsum